D9-Tetrahydrocannabinol-Thc Medical Cannabis Studies

A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol (2006)

The combination of tetrahydrocannabinol and cannabidiol increases clinical efficacy in the treatment of spasticity, central pain, lower urinary tract symptoms in multiple sclerosis, sleep disorders, peripheral neuropathic pain, avulsion symptoms of the branchial plexus, arthritis rheumatoid pain and intractable cancer, in addition to reducing the occurrence of adverse effects. View study
Activity of cannabis in relation to its delta'-trans-tetrahydro-cannabinol content (1981)

Tetrahydrocannabinol (THC) can represent about one third of the activity of the herb or cannabis resin. In this study it has been shown that some fractions of the crude drug show an inhibitory effect, while others have a THC enhancing effect, which can have an important influence on the types of cannabis preparation used. View study
Constantino1997_PosTHC_HempSeed - Hemp Oil Ingestion Causes Positive Urine Tests for Ag-Tetrahydrocannabinol Carboxylic Acid (1997)

Through the urine samples taken from 7 volunteers who consumed 15 milliliters of hemp oil, it was concluded that all the publication samples showed the presence of tetrahydrocannabinol carboxylic acid (THCA) by GC-MS. View study
Consumption and Quantitation of D9-Tetrahydrocannabinol in Commercially Available Hemp Seed Oil Products (2000)

This research aims to quantify the levels of Ag-tetrahydrocannabinol THC in hemp oils available in the market and administer the analyzed oils to volunteers without THC to determine the levels of metabolites in the urine after several doses of 15 g. View study